Safety and Effectiveness Analysis of Dolutegravir in Patients with HIV-1: Interim Report of Post-Marketing Surveillance in Japan.
Adv Ther
; 38(8): 4480-4504, 2021 08.
Article
in En
| MEDLINE
| ID: mdl-34275116
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
HIV-1
/
Anti-HIV Agents
Type of study:
Observational_studies
/
Risk_factors_studies
/
Screening_studies
Limits:
Humans
Country/Region as subject:
Asia
Language:
En
Journal:
Adv Ther
Journal subject:
TERAPEUTICA
Year:
2021
Document type:
Article
Affiliation country:
Japan
Country of publication:
United States